OB Mobile Logo

Search form


Breast Health

Breast Health

Women with primary breast cancer diagnosed at an advanced stage are at increased risk for the development of contralateral breast cancer (CBC), according to the results of a population-based study conducted in Sweden.

The FDA has approved a new ultrasound device to detect breast cancer in women with dense breasts. It will be used in conjunction with standard mammography in asymptomatic women with a negative mammogram.

In patients with heavily pretreated HER2-positive metastatic breast cancer, combination treatment with lapatinib and trastuzumab was associated with a median survival benefit of 4.5 months, according to the final results of a phase III study.

The findings of several recent studies involving breast cancer is lending further evidence to the idea that genetics and genomics will soon be the primary focus of diagnosing and treating cancer.

The benefits and risks of breast cancer screening have often been debated by the clinical and epidemiological realms, with key arguments centering around overdiagnosis.

The association between breast cancer and cadmium, a heavy metal that can be found in food, cosmetics, water, and air, has been explored in several new studies with varied findings.

Fatigue, which can plague patients’ years after cancer treatment has ended, may be the result of inflammation. Now, a new study published in the Journal of Clinical Oncology has found that omega-3 may help reduce fatigue associated with inflammation in these patients.


Subscribe to Breast Health on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.